Average Co-Inventor Count = 5.03
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novozymes Adenium Biotech A/s (6 from 8 patents)
2. Novozymes A/s (3 from 1,371 patents)
3. Defensin Therapeutics Aps (2 from 4 patents)
4. Adenium Biotech Aos (1 from 1 patent)
5. Novozymes Adenivro Biotech A/s (1 from 1 patent)
6. Novozymes Pharma Biotec A/s (1 from 1 patent)
7. Novozymes Aderium Biotech A/s (1 from 1 patent)
8. Adenium Biotech Aps (1 patent)
15 patents:
1. 9279010 - Treatment of inflammatory bowel diseases with mammal beta defensins
2. 8835604 - Antimicrobial peptide variants and polynucleotides encoding same
3. 8802621 - Treatment of inflammatory bowel diseases with mammal beta defensins
4. 8232242 - Treatment of inflammatory bowel diseases with mammal beta defensins
5. 8232248 - Treatment of rheumatoid arthritis with mammal beta defensins
6. 8192925 - Polypeptides having antimicrobial activity and polynucleotides encoding same
7. 8080390 - Antimicrobial polypeptides
8. 7972814 - [object Object]
9. 7935501 - Recombinant production of antimicrobial peptides
10. 7893196 - Polypeptides having antimicrobial activity and polynucleotides encoding same
11. 7829524 - Antimicrobial peptides
12. 7671175 - Polypeptides having antimicrobial activity and polynucleotides encoding same
13. 7504375 - Antimicrobial polypeptides
14. 7388077 - Polypeptides having antimicrobial activity and polynucleotides encoding the same
15. 7148404 - Antimicrobial polypeptides